Sitemap - 2017 - The California Stem Cell Report
A Rare, Written Self-Exploration: California's Stem Cell Agency Slices and Dices its Own Spending
$5 Billion Bond Measure: California Stem Cell Agency Sets a Course to Secure Its Financial Future
$68 Million Saving: California Stem Cell Agency Cuts Size of Clinical Trial Awards
The California Stem Cell Agency, 'Lost' Opportunities and its Financial Lifeblood
California Stem Cell Board to Hash Over Cuts, Future Financing Plans Next Week
California Stem Cell Research and a 'Heart-Tugging Media Blitz'
Hope and the 'Helping Patients Part': The Uncertain Future of California's Stem Cell Program
California Researchers Score $16 Million Plus in State Stem Cell Awards
Balloting on Stem Cell Person of the Year: Cast Your Vote Now
California Stem Cell Agency Examines its Financial Options Long-Term and Short-Term
California Tightening Stem Cell Research Belt; Size of Research Awards Targeted
More California Millions Sought to Support the 'New Era' of Parkinson's Therapy Research
'Critical Stage' for $3 Billion California Stem Cell Effort and its Search for More Cash
Financial Examination of California Stem Cell Agency: Fireworks Not Expected
The California Stem Cell Story: Key to Extending the Life of a $3 Billion Agency
CEO Millan on the Prospects for California's $3 Billion Stem Cell Research Effort
'Invisible Work' and the California Stem Cell Agency
Research for Arthritic Knee Treatment Survives Challenge at California Stem Cell Agency
Stem Cells, Anonymous Commentary and Silence Dogood
Public Welcome: California Stem Cell Agency Holding Show-and-Tell Session Next Monday
ViaCycte Update: Clinical Trials for a Diabetes Device Plus the Rain Gear Connection
CIRM-funded ALS Trial Enrolls First Patients; Therapy Produced by Israeli Firm
Internet Outage for California Stem Cell Agency Earlier This Week: Cause Unknown
Probing California's Stem Cell Trials: New Tool Helps Public Navigate the Multi-Million Dollar Maze
Forty-three Percent Jump in Interest in California Stem Cell Internet Information
California Moves to Protect Patients Seeking Unregulated Stem Cell Treatments
$75 Million For California Stem Cell Research: Brain Cancer, Sickle Cell, Alpha Clinics and More
'Right Person at Right Time:' Maria Millan Named as CEO of California Stem Cell Agency
California Stem Cell Board in Executive Session on New President
Tap into Stem Cell Agency's Meeting Tomorrow
Alpha Clinic Expansion: California Stem Cell Agency to Award $7.9 Million to UC Davis
$80 Million Stem Cell Infusion Coming Up in California
New President Coming Up for California Stem Cell Agency: Maria Millan Likely Choice
Ballot Measures to Mergers: California Stem Cell Agency Examines Alternatives to Its Demise
California Stem Cell Agency: $20 Million Cancer Award from 2012 Bears Clinical Trial Fruit
Curtailing Research Awards and Other End-of-Life Matters at California Stem Cell Agency
San Francisco Business Times: Can Clinical Trials Save California's Stem Cell Agency?
The Dual Images of Stem Cell Medicine Highlighted in the Headlines
$400 Million Deal Leaves California-backed HIV Trial Hanging
$185 Million California Rumpus over Researcher Raiding
Thinking About Its Demise: California Stem Cell Agency Launches Examination of Alternatives
Crossing the Two Million Mark: A Dozen Years of Readership on the California Stem Cell Report
The Demise of California's Stem Cell Agency: Gone in Three Years or Perhaps Some Other Date?
'A Reliable Voice of Reason:' A Look at a California Stem Cell Researcher/Blogger
California Stem Cell CEO Search: Lid Still on Until Late September
The Smell of Money and Gene Editing of Human Embryos -- Not to Mention the Breakthrough Science
Zipped Up in Oakland: California Stem Cell Agency Mute on Search for New CEO
An FDA Signal: Good News for California's Stem Cell Agency's Search for Therapies
USA Today Reports on Financial Complaints Involving Stemedica
Former USC Med School Dean Loses Board Seat at $3 Billion California Stem Cell Agency
NY Times: The Race to Create 'Transformative' Cellular Treatments for Cancer
McCain's Cancer and the California Stem Cell Agency: The Promising Approaches of Genetic Engineering
'Secret Life' Flap: Former USC Med School Dean-Stem Cell Agency Board Member on Leave from School
LATimes: 'Secret Life' of Former USC Med School Dean and California Stem Cell Agency Director
Two Rounds of Transplants, 70 Drugs: An Advocate's Journey into Stem Cell Safety
California's Stem Cell CEO Search: $3 Billion Agency Needs New President
Alpha Thalassemia to Strokes to Zika: A $64 Million Boost by California for Stem Cell Research
Plans Scrubbed for a 2018 Bond Measure for California Stem Cell Research
CIRM Directors Open Morning Meeting
Conflict List for CIRM Directors Clinical and Preclinical Awards
Check Out All the Breaking California Stem Cell News Tomorrow -- Right Here on This Web Site
Seeking a CEO: $3 Billion California Stem Cell Agency Faces Critical Leadership Challenges
Guest Posting: "Stem Cell Options Should be on the Table"
California Stem Cell Agency Reports 'Streak of Good News' on Asterias Spinal Therapy
California Stem Cell Report Going Dark for a Few Days
A Longer Look at the Golden State's Stem Cell Research Efforts
Full Text: The California Stem Cell Agency's Response on its Accomplishments
A Look at the California Stem Cell Agency: Its Origins, Its Accomplishments and Its Future
Major Overview of California Stem Cell Upcoming This Afternoon
California Stem Cell Agency Has Opportunity for 'All-in" Executive Assistant
Bones, Stem Cells and Bridging the Gap
Read All About It! Bad News for The Stem Cell 'Other'
$20 Million, California-backed Stem Cell Trial Discloses Disappointing News
The "Other" and Stem Cell Blogs
Embedded in a Stem Cell Lab: Melton, Diabetes and Keeping Cells Happy
A Scripps Scientist Deflates Cancer-Stem Cell Nexus
NY Times Offers Overview of $3 Billion California Stem Program
More Media: San Diego Weighs in With Story on Randy Mills' Departure from Stem Cell Agency
Mills' Departure: Surprise and Concern About California Stem Cell Agency
California's $3 Billion Stem Cell Agency Loses CEO Randy Mills
Asterias and Capricor: Good News for California's Stem Cell Research Effort
The Journal Nature Says: 'Last Stage' for California's Stem Cell Research Program
California Stem Cell Agency Plumps Its Program as It Eyes Need for More Funding
UC Irvine Stem Cell Blog: Troubling New Federal Law on Stem Cell Research
New Top Lawyer Likely Coming Soon to California's $3 Billion Stem Cell Agency
California's Unregulated Stem Cell Clinics: Will State Regulators Step In to Cure Abuses?
California's Alpha Stem Cell Clinics: A 21-Video Overview of the $40 Million Effort
State Lawmaker Aims to End California Stem Cell Program, Calls It a 'Boondoggle'
Slim Coverage of California's Ambitious Alpha Stem Cell Clinic Network
Fresh $5 Billion for California Stem Cell Research? Voter Poll Scheduled for This Fall
Alpha Clinic Session Streaming Live Today
The Gottlieb Effect: Dismantling of FDA Silos, Less Regulation of Stem Cells?
California Stem Cell Agency Says Its Top Lawyer Is Departing After More Than 12 years
A "Blind" Warning to Patients: Beware Unproven, Unregulated Stem Cell Treatments
California's Alpha Clinics: A Unique, Stem Cell 'Clincher' for Patients, Doctors and Researchers
California Award Recipient: 'Promising' Results from Chinese Stem Cell Trial for Knee Arthritis
California Popping for $40 Million for its Alpha Clinic Stem Cell Centers
Diabetes to Arthritis: California Awards $33 Million for Clinical Stage Stem Cell Work
California Stem Cell Agency Ends Today's Session
First Time: California Stem Cell Directors Open Session in CIRM HQ in Oakland
Looking at CIRM's Clinical Trials: Focus on Opthalmology
Defying Basic Medical Know-how, Stem Cell Treatments and Fake News
California to Hand Out $32 Million for Stem Cell Research Next Week
Cost of a Stem Cell Therapy? An Estimated $900,000
Sampling Stem Cell News: $1 Million Gift, Unsettling Thoughts and Paolo Macchiarini
Politics Could Be Key to Future of California's $3 Billion Stem Cell Program
Clarifying the Path to Cash: California Looking for Money from Its Stem Cell Investments
From Cystic Fibrosis to Zika: California Awards $21 Million for Stem Cell Research
STAT News: California Slow on its Stem Cell Clinical Trials Over Last 10 Years
The 'Overstated' Stem Cell Debate: A Perspective from the California Stem Cell Agency
$16 Million Expansion of Alpha Stem Cell Clinics Planned for California
The $22,000-an-Hour California Stem Cell Story: Rosy Expectations, Fuzzy Future
Text of Comments from John M. Simpson of Consumer Watchdog
Latest Targets of the California Stem Cell Agency: $26 Million for Zika, Heart Disease and Much More
Update: Lengthier Look at CIRM Delayed
California Stem Cell Agency Director Sheehy Named to SF Board of Supervisors
The 2016 Report From the California Stem Cell Agency: Challenges and Accomplishments